Literature DB >> 34219929

COVID-19 infection and severe rhabdomyolysis.

Vishal Patel1, Bashar Alzghoul2, Saminder Singh Kalra2.   

Abstract

Although patients with COVID-19 can have mild nonspecific myalgia and mild elevation of creatinine kinase levels, severe myalgia along with elevation of creatinine kinase levels >10 times the upper normal limit and dark-colored urine indicate an underlying severe rhabdomyolysis. This report describes a 60-year-old morbidly obese man who was found to have severe rhabdomyolysis, along with acute kidney injury, dark-colored urine, and a positive COVID-19 test. He had a prolonged hospital course requiring continuous renal replacement therapy, mechanical ventilation, and multiple vasopressors and eventually died of multiorgan failure. The management of severe rhabdomyolysis and COVID-19 is challenging, and fluid resuscitation should be done cautiously, monitoring for early signs of fluid overload.
Copyright © 2021 Baylor University Medical Center.

Entities:  

Keywords:  COVID-19; SARS-COV-2; respiratory failure; rhabdomyolysis

Year:  2021        PMID: 34219929      PMCID: PMC8224192          DOI: 10.1080/08998280.2021.1897341

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  4 in total

Review 1.  Rhabdomyolysis.

Authors:  W H Bagley; H Yang; K H Shah
Journal:  Intern Emerg Med       Date:  2007-10-01       Impact factor: 3.397

Review 2.  Rhabdomyolysis: review of the literature.

Authors:  R Zutt; A J van der Kooi; G E Linthorst; R J A Wanders; M de Visser
Journal:  Neuromuscul Disord       Date:  2014-05-21       Impact factor: 4.296

3.  Rhabdomyolysis as the main manifestation of coronavirus disease 2019.

Authors:  S Rivas-García; J Bernal; J Bachiller-Corral
Journal:  Rheumatology (Oxford)       Date:  2020-08-01       Impact factor: 7.580

4.  Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease.

Authors:  Kulachanya Suwanwongse; Nehad Shabarek
Journal:  Cureus       Date:  2020-04-06
  4 in total
  2 in total

Review 1.  The Musculoskeletal Involvement After Mild to Moderate COVID-19 Infection.

Authors:  Patty K Dos Santos; Emilly Sigoli; Lorenna J G Bragança; Anabelle S Cornachione
Journal:  Front Physiol       Date:  2022-03-18       Impact factor: 4.755

Review 2.  Highly pathogenic coronaviruses and the kidney.

Authors:  Fang Wang; Xiao-Guo Suo; Cong Wang; Jia-Nan Wang; Xiao-Yan He; Fa-Cai Wang; Juan Jin; Jia-Gen Wen; Wei-Jian Ni; Bing-Xiang Shen; Xiao-Ming Meng
Journal:  Biomed Pharmacother       Date:  2022-10-11       Impact factor: 7.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.